Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lite Strategy, Inc. Director's Dealing 2020

Apr 14, 2020

34267_dirs_2020-04-14_c8daf5a7-5997-4635-8617-2a5dd8cade4a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2020-04-10

Reporting Person: Cohen Cheryl (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 0 Direct